A new antibiotic has been discovered that has been found to treat many common bacterial infections. Incredibly, no resistance has been detected so far. The research was published this week in the journal Nature.
Screen Shot 2014-12-23 at 1.46.58 PMNormally, this wouldn t even make the news. A new antibiotic approved. Not only that, but it belongs to a class of antibiotics (called cephalosporins) from the class of 1960s, which is hardly novel. There are about 60 cephalosporins that have been approved since 1964, when cephalothin was launched by Lilly.
Anaphylaxis (a severe, systemic allergic reaction) can be life-threatening. While this life-threatening reaction is quite uncommon, among the commonest causes of anaphylaxis include drug allergies, food allergies, and insect bites and stings. People who are known to be
By the age of two, one in ten children are considered obese. Considering that obesity early in life puts one at greater risk of obesity later in life, childhood obesity is something to pay attention to. Now, a new study
How do you ensure that the FDA advisory panels crucial to the drug approval process have the right members? ACSH advisor Dr. David Shlaes, the former head of infectious disease research at Wyeth, addresses these issues especially as they relate to antibiotic panels in his recent thought-provoking entry entitled Conflict of Interest vs. Competent Advice.
The latest health news: Our take on the Ebola outbreak, why your smartphone isn't as smart as it could be, and how Europe is overcoming the antibiotic resistance crisis
In a hard-hitting op-ed in today s NY Times, food writer Ruth Reichl takes the FDA to task for not taking strong action to limit or ban the use of antibiotics in food animals.
We at ACSH have written frequently about the misguided change in mindset by the FDA two decades ago that brought most antibiotic research to a dead stop. No one has been deeper in the FDA trenches than ACSH advisor and infectious disease expert Dr. David Shlaes. He has been blogging, advising, lobbying, begging, and doing just about everything short of pulling his hair out to convince the infectious disease division of the FDA to reverse the disastrous changes in clinical trial policy that caused almost all drug companies to abandon research in this area.
A new study published online in the journal Annals of Allergy, Asthma, and Immunology raises some interesting questions about whether very young children who receive antibiotics develop asthma more frequently than those who do not.
Get the latest news on the costly Hepatitis C drug, why C-sections have skyrocketed in numbers, and the real reason behind the lack of research on antibiotic research
While it s good to see that The New York Times is taking note of the crisis of antibiotic resistance, it is unfortunate that they could not be
The emergence of antibiotic-resistant bacteria, in particular a strain of Staphlococcus aureus (SA ) resistant to methicillin (MRSA) (a member of the fluoroquinolone class of drugs) has concerned physicians and caused hospitals to review and revamp their sanitation procedures.